|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0185117,
umls-concept:C0332281,
umls-concept:C0580822,
umls-concept:C0868928,
umls-concept:C1412323,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C2239176,
umls-concept:C2603343,
umls-concept:C2911684
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-6-7
|
|
pubmed:abstractText |
The detoxification enzyme AKR1B10, a member of the aldo-keto reductase superfamily, is discussed as a new biomarker candidate for hepatocellular carcinoma (HCC). Only rare clinicopathological data on AKRB1B10 in HCC exist. This retrospective study determines the diagnostic and prognostic relevance of AKR1B10 expression in HCC and its relationship to a series of clinicopathological parameters including underlying aetiological factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1478-3231
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2011 John Wiley & Sons A/S.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
810-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21645211-Aldehyde Reductase,
pubmed-meshheading:21645211-Apoptosis,
pubmed-meshheading:21645211-Carcinoma, Hepatocellular,
pubmed-meshheading:21645211-Catheter Ablation,
pubmed-meshheading:21645211-Cell Proliferation,
pubmed-meshheading:21645211-Chemoembolization, Therapeutic,
pubmed-meshheading:21645211-Chi-Square Distribution,
pubmed-meshheading:21645211-Disease-Free Survival,
pubmed-meshheading:21645211-Female,
pubmed-meshheading:21645211-Hepatectomy,
pubmed-meshheading:21645211-Humans,
pubmed-meshheading:21645211-Immunohistochemistry,
pubmed-meshheading:21645211-Kaplan-Meier Estimate,
pubmed-meshheading:21645211-Liver Neoplasms,
pubmed-meshheading:21645211-Liver Transplantation,
pubmed-meshheading:21645211-Male,
pubmed-meshheading:21645211-Neoplasm Staging,
pubmed-meshheading:21645211-Proportional Hazards Models,
pubmed-meshheading:21645211-Retrospective Studies,
pubmed-meshheading:21645211-Risk Assessment,
pubmed-meshheading:21645211-Risk Factors,
pubmed-meshheading:21645211-Survival Analysis,
pubmed-meshheading:21645211-Time Factors,
pubmed-meshheading:21645211-Tissue Array Analysis,
pubmed-meshheading:21645211-Treatment Outcome,
pubmed-meshheading:21645211-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
|
|
pubmed:affiliation |
Institute of Pathology and Neuropathology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
